Overview


According to FutureWise analysis the market for lower extremities is expected to register a CAGR of 8.22% from 2023-2031.

The lower limb of a human is composed of the hips and extends up to the ankle. This portion of the lower limb is known as the lower extremity. The lower extremity region is responsible for basic functions, coordination, and movements, such as running, standing, kicking, jumping, and others. Arthritis, inflammation, and stiffness of joints are among the diseases that affect the lower extremities. Extremity products are used to treat, repair, replace, or heal injuries to the extremities, such as fractures and damage. External recovery braces, surgical implants, joint replacements, biologics, and external support implants are included in this category. Due to the increasing number of knee and hip arthroplasty procedures and revision procedures, braces and supporting systems will drive the overall growth of the market. Furthermore, an increase in bone-related disorders and a rise in geriatric populations boost the growth of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Lower Extremities Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Lower Extremities Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • DePuy Synthes
  • Stryker
  • Zimmer Biomet
  • Active Implants
  • Acumed
  • Arthrex
  • Avitus Orthopaedics
  • Biotech Limb and Brace
  • Bioventus
  • Bone Therapeutics
  • Bone Biologics
  • Ceramisys
  • ConforMIS
  • CONMED
  • CollPlant
  • DJO Global
  • Evolutis
  • Exactech
  • FH Orthopedics
  • Graftys
  • ICONACY Orthopedic Implants
  • Integra LifeSciences
  • implantcast
  • Isto Biologics
  • Lima Corporate
  • Medtronic
  • Merete Group
  • Össur
  • OsteoMed
  • Orthofix
  • Orthogem
  • Promedics Orthopaedic
  • Regenexx
  • RTI Surgical
  • Sigma Graft
  • Silver Bullet Therapeutics
  • Skye Biologics
  • Smith and Nephew
  • Stanmore Implants Worldwide
  • Surgical Appliance Industries
  • Wright Medical Group
  • Xtant Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Braces and supporting systems
  • Orthobiologics
  • Accessories

By End User

  • Hospitals and clinics
  • ASCs

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Lower Extremities Market By Product, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Lower Extremities Market Variables, Trends & Scope
    •         1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Lower Extremities Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Lower Extremities Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Lower Extremities Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Braces and supporting systems
        2. Orthobiologics
        3. Accessories

  • 8.   Lower Extremities Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and clinics
        2. ASCs

  • 9.   North America Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. DePuy Synthes
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Stryker
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Zimmer Biomet
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Active Implants
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Acumed
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Arthrex
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Avitus Orthopaedics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Biotech Limb and Brace
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Bioventus
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Bone Therapeutics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Bone Biologics
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Ceramisys
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. ConforMIS
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. CONMED
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. CollPlant
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. DJO Global
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Evolutis
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Exactech
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. FH Orthopedics
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Graftys
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. ICONACY Orthopedic Implants
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Integra LifeSciences
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         2.4. Financial Overview
         22.5. Strategic Overview
        23. implantcast
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24. Isto Biologics
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25. Lima Corporate
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview
        26. Medtronic
         26.1. Company Overview
         26.2. Product Portfolio
         26.3. SWOT Analysis
         26.4. Financial Overview
         26.5. Strategic Overview
        27. Merete Group
         27.1. Company Overview
         27.2. Product Portfolio
         27.3. SWOT Analysis
         27.4. Financial Overview
         27.5. Strategic Overview
        28. Össur
         28.1. Company Overview
         28.2. Product Portfolio
         28.3. SWOT Analysis
         28.4. Financial Overview
         28.5. Strategic Overview
        29. OsteoMed
         29.1. Company Overview
         29.2. Product Portfolio
         29.3. SWOT Analysis
         29.4. Financial Overview
         29.5. Strategic Overview
        30. Orthofix
         30.1. Company Overview
         30.2. Product Portfolio
         30.3. SWOT Analysis
         30.4. Financial Overview
         30.5. Strategic Overview
        31. Orthogem
         31.1. Company Overview
         31.2. Product Portfolio
         31.3. SWOT Analysis
         31.4. Financial Overview
         31.5. Strategic Overview
        32. Promedics Orthopaedic
         32.1. Company Overview
         32.2. Product Portfolio
         32.3. SWOT Analysis
         32.4. Financial Overview
         32.5. Strategic Overview
        33. Regenexx
         33.1. Company Overview
         33.2. Product Portfolio
         33.3. SWOT Analysis
         33.4. Financial Overview
         33.5. Strategic Overview
        34. RTI Surgical
         34.1. Company Overview
         34.2. Product Portfolio
         34.3. SWOT Analysis
         34.4. Financial Overview
         34.5. Strategic Overview
        35. Sigma Graft
         35.1. Company Overview
         35.2. Product Portfolio
         35.3. SWOT Analysis
         35.4. Financial Overview
         35.5. Strategic Overview
        36. Silver Bullet Therapeutics
         36.1. Company Overview
         36.2. Product Portfolio
         36.3. SWOT Analysis
         36.4. Financial Overview
         36.5. Strategic Overview
        37. Skye Biologics
         37.1. Company Overview
         37.2. Product Portfolio
         37.3. SWOT Analysis
         37.4. Financial Overview
         37.5. Strategic Overview
        38. Smith & Nephew
         38.1. Company Overview
         38.2. Product Portfolio
         38.3. SWOT Analysis
         38.4. Financial Overview
         38.5. Strategic Overview
        39. Stanmore Implants Worldwide
         39.1. Company Overview
         39.2. Product Portfolio
         39.3. SWOT Analysis
         39.4. Financial Overview
         39.5. Strategic Overview
        40. Surgical Appliance Industries
         40.1. Company Overview
         40.2. Product Portfolio
         40.3. SWOT Analysis
         40.4. Financial Overview
         40.5. Strategic Overview
        41. Wright Medical Group
         41.1. Company Overview
         41.2. Product Portfolio
         41.3. SWOT Analysis
         41.4. Financial Overview
         41.5. Strategic Overview
        42. Xtant Medical
         42.1. Company Overview
         42.2. Product Portfolio
         42.3. SWOT Analysis
         42.4. Financial Overview
         42.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients